Nuo Therapeutics, Inc. (AURX) Gross profit 2015–2025
Nuo Therapeutics, Inc. (AURX) annual gross profit history from SEC filings — each fiscal year as reported.
$2.2MFY2025 · since FY2015: $3.5M → $2.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.2M | +108.8% |
| FY2024 | $1.1M | +120.2% |
| FY2023 | $482,433 | +418.5% |
| FY2022 | $93,036 | — |
| FY2021 | $0 | — |
| FY2020 | $0 | -100.0% |
| FY2019 | $31,563 | -97.4% |
| FY2018 | $1.2M | +426.4% |
| FY2017 | -$369,997 | — |
| FY2015 | $3.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice